Patient-Reported Outcome Measures in Inflammatory Bowel Disease
Patient-reported outcome measures (PROMs) are increasingly used in both research and clinical health settings. With the recent development of United States Food and Drug Administration guidance on PROMs, more attention is being devoted to their role and importance in health care. Several methodologi...
Main Author: | Wael El-Matary |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2014-01-01
|
Series: | Canadian Journal of Gastroenterology and Hepatology |
Online Access: | http://dx.doi.org/10.1155/2014/792386 |
Similar Items
-
Advances in Nutritional Management of Pediatric Inflammatory Bowel Disease
by: Wael El-Matary
Published: (2021-01-01) -
Cancer Risk in Pediatric-Onset Inflammatory Bowel Disease
by: Wael El-Matary, et al.
Published: (2020-07-01) -
Barriers to clinical research in children with inflammatory bowel disease: The patients' perspective.
by: Wael El-Matary, et al.
Published: (2018-01-01) -
Micronutrient Deficiencies and Anemia in Children with Inflammatory Bowel Disease
by: Julie Rempel, et al.
Published: (2021-01-01) -
The Utility of Fecal Calprotectin in the Real-World Clinical Care of Patients with Inflammatory Bowel Disease
by: Esmail Abej, et al.
Published: (2016-01-01)